Go Back
Logos Capital
Logos Capital, a San Francisco-based venture fund established in 2019, specializes in Series B, C, and D investments in Biotech, Life Science, Healthcare, and Medical Device sectors. Led by Partner Arsani William, the fund has invested in companies like Parse Biosciences, Gennao Bio, and Odyssey Therapeutics. With 86 investments and 45 exits, Logos Capital focuses on fundamental biotechnology investments. For more details, visit their website at logoscapital.com.
About
About
About
Bio
Logos Capital is a fundamental biotechnology-focused investment fund.
Location
San Francisco
Stage
Series C, Series D, Series B
Partner name
Arsani William
Bio
Logos Capital is a fundamental biotechnology-focused investment fund.
Location
San Francisco
Stage
Series C, Series D, Series B
Partner name
Arsani William
Fund
Fund
Fund
Fund Focus
BioTech, Life Science, Healthcare, Medical Device
Number of investments
86
Number of exits
45
Fund Type
Venture Fund
Portfolio Companies
Parse Biosciences, Gennao Bio, Odyssey Therapeutics
Logos Capital
Logos Capital, a San Francisco-based venture fund established in 2019, specializes in Series B, C, and D investments in Biotech, Life Science, Healthcare, and Medical Device sectors. Led by Partner Arsani William, the fund has invested in companies like Parse Biosciences, Gennao Bio, and Odyssey Therapeutics. With 86 investments and 45 exits, Logos Capital focuses on fundamental biotechnology investments. For more details, visit their website at logoscapital.com.
About
Bio
Logos Capital is a fundamental biotechnology-focused investment fund.
Location
San Francisco
Stage
Series C, Series D, Series B
Partner name
Arsani William
Fund
Fund Focus
BioTech, Life Science, Healthcare, Medical Device
Number of investments
86
Number of exits
45
Fund Type
Venture Fund
Portfolio Companies
Parse Biosciences, Gennao Bio, Odyssey Therapeutics